AT432076T - New methods and procedures for the treatment and prevention of ileus - Google Patents

New methods and procedures for the treatment and prevention of ileus

Info

Publication number
AT432076T
AT432076T AT00992255T AT00992255T AT432076T AT 432076 T AT432076 T AT 432076T AT 00992255 T AT00992255 T AT 00992255T AT 00992255 T AT00992255 T AT 00992255T AT 432076 T AT432076 T AT 432076T
Authority
AT
Austria
Prior art keywords
ileus
prevention
procedures
treatment
new methods
Prior art date
Application number
AT00992255T
Other languages
German (de)
Inventor
John Farrar
Peter Schied
William Schmidt
Randall Carpenter
Original Assignee
Adolor Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US45092099A priority Critical
Application filed by Adolor Corp filed Critical Adolor Corp
Priority to PCT/US2000/042313 priority patent/WO2001042207A2/en
Publication of AT432076T publication Critical patent/AT432076T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
AT00992255T 1999-11-29 2000-11-29 New methods and procedures for the treatment and prevention of ileus AT432076T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US45092099A true 1999-11-29 1999-11-29
PCT/US2000/042313 WO2001042207A2 (en) 1999-11-29 2000-11-29 Novel methods for the treatment and prevention of ileus

Publications (1)

Publication Number Publication Date
AT432076T true AT432076T (en) 2009-06-15

Family

ID=23790061

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00992255T AT432076T (en) 1999-11-29 2000-11-29 New methods and procedures for the treatment and prevention of ileus

Country Status (14)

Country Link
EP (1) EP1244448B1 (en)
JP (2) JP5079961B2 (en)
AT (1) AT432076T (en)
AU (2) AU780738B2 (en)
CA (1) CA2393141C (en)
CY (1) CY1109264T1 (en)
DE (1) DE60042282D1 (en)
DK (1) DK1244448T3 (en)
ES (1) ES2329004T3 (en)
IL (2) IL149650D0 (en)
MX (1) MXPA02005336A (en)
NZ (1) NZ518684A (en)
PT (1) PT1244448E (en)
WO (1) WO2001042207A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274591B1 (en) 1997-11-03 2001-08-14 Joseph F. Foss Use of methylnaltrexone and related compounds
EP1615646B1 (en) 2003-04-08 2014-12-24 Progenics Pharmaceuticals, Inc. Pharmaceutical formulations containing methylnaltrexone
US6992090B2 (en) * 2003-06-16 2006-01-31 Adolor Corporation Substituted piperidine compounds and methods of their use
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
CN104248763A (en) 2005-03-07 2014-12-31 芝加哥大学 Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
AR057035A1 (en) 2005-05-25 2007-11-14 Progenics Pharm Inc Synthesis of (R) -N-methylnaltrexone, PHARMACEUTICAL COMPOSITIONS AND USES
AR057325A1 (en) 2005-05-25 2007-11-28 Progenics Pharm Inc Synthesis (s) -n-methylnaltrexone, pharmaceutical compositions and uses
CN101426481B (en) 2006-04-21 2012-12-05 帝斯曼知识产权资产管理有限公司 Use of opioid receptor antagonists
US8546418B2 (en) 2007-03-29 2013-10-01 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
DK2565195T3 (en) 2007-03-29 2015-06-29 Wyeth Llc And peripheral opioid receptor antagonists, and uses thereof
EP3263571A1 (en) 2007-03-29 2018-01-03 Progenics Pharmaceuticals, Inc. Crystal form of (r)-n-methylnaltrexone bromide and uses thereof
JP5358587B2 (en) 2008-02-06 2013-12-04 プロジェニックス・ファーマシューティカルス・インコーポレイテッドProgenics Pharmaceuticals, Inc. (R), (r) -2,2'- bis - methylnaltrexone production and use
US8685995B2 (en) 2008-03-21 2014-04-01 The University Of Chicago Treatment with opioid antagonists and mTOR inhibitors
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
RU2455943C1 (en) * 2011-02-01 2012-07-20 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО РГМУ Росздрава) Method of treating obturative form of acute adhesive obstruction of small intestine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1420015B1 (en) * 1959-10-16 1971-08-26 Boehringer Sohn Ingelheim 2'-hydroxy-5,9-dimethyl-6,7-benzomorphans
US4176186A (en) * 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
FR2514644B1 (en) * 1981-10-19 1984-04-20 Sanofi Sa
JPH045647B2 (en) * 1982-03-16 1992-02-03 Univ Rockefeller
US4806556A (en) * 1985-12-12 1989-02-21 Regents Of The University Of Minnesota Gut-selective opiates
US4730048A (en) * 1985-12-12 1988-03-08 Regents Of The University Of Minnesota Gut-selective opiates
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
US6274591B1 (en) * 1997-11-03 2001-08-14 Joseph F. Foss Use of methylnaltrexone and related compounds

Also Published As

Publication number Publication date
DK1244448T3 (en) 2009-08-17
DE60042282D1 (en) 2009-07-09
AU3970501A (en) 2001-06-18
CA2393141C (en) 2013-08-13
ES2329004T3 (en) 2009-11-20
EP1244448A2 (en) 2002-10-02
IL149650A (en) 2011-02-28
NZ518684A (en) 2003-11-28
JP2012162560A (en) 2012-08-30
WO2001042207A3 (en) 2002-05-02
JP2003517476A (en) 2003-05-27
PT1244448E (en) 2009-06-30
AU2005203041B2 (en) 2009-01-08
AU780738B2 (en) 2005-04-14
CA2393141A1 (en) 2001-06-14
MXPA02005336A (en) 2003-01-28
AU2005203041A1 (en) 2005-08-04
CY1109264T1 (en) 2014-07-02
IL149650D0 (en) 2002-11-10
WO2001042207A2 (en) 2001-06-14
JP5079961B2 (en) 2012-11-21
EP1244448A4 (en) 2003-06-25
EP1244448B1 (en) 2009-05-27
JP5460771B2 (en) 2014-04-02

Similar Documents

Publication Publication Date Title
DE60120667D1 (en) Methods and medium for treatment of bandscheibenverschleiss
DE60019556D1 (en) 2-amino-benzoxazinonderivate for treatment of obesity
DE60010666D1 (en) Method and apparatus for programmably treating fluids
DE69535530D1 (en) Vaccine and anti-toxins for the treatment and prevention of C. difficile disease
DE60138129D1 (en) Apparatus for treatment of teeth
DE60021063D1 (en) Vorichtung for treatment of tissue
DE69831567D1 (en) Device for treatment of herzarrhythien
DE60044057D1 (en) Compounds, compositions and methods for the treatment or prevention of Alzheimer's disease
DE60042676D1 (en) Device and method for the selection of network units
DE60132081D1 (en) PREPARATION FOR THE PREVENTION AND TREATMENT OF vascular diseases
DE69122099T2 (en) Composition and method for the prevention and treatment of hypercholesterolemia and zellproliferationsstorungen
DE60123660D1 (en) Method and device for the assessment of boundary lines
DE69916435D1 (en) Process for improving the ductilität of nitinol
AT414165T (en) Methods and compositions for the best of mung zellülaren response-profile
DE60116600D1 (en) Apparatus for the treatment of anal incontinence
DE69730245D1 (en) A process for the treatment of metal parts
DE60332483D1 (en) Methods for prevention and treatment of cancer-metastasis and cancer-metastasis concomitant bone loss
AT328670T (en) Apparatus and methods for administering drops
DE60135732D1 (en) Topoisomerase inhibitors for the treatment of surgical adhesions
DE60105295D1 (en) Quinazoline derivatives for the treatment of tumors
DE69730353D1 (en) Devices, methods and arrangements for tightening of tissue
DE69934701D1 (en) A method for the treatment of fluids
DE69725169D1 (en) Compositions and methods for stimulating the growth of neurites
DE69829115D1 (en) Compositions and methods for treatment of hepatitis C virus-related disorders
DE60037406D1 (en) Inflatable device for treatment of glaucoma

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1244448

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1244448

Country of ref document: EP

REN Ceased due to non-payment of the annual fee